Osaic Holdings
ADMA icon

Osaic Holdings’s ADMA Biologics ADMA Stock Holding History

Osaic Holdings’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$283K Buy
33,798
+3,147
+10% +$28.7K ﹤0.01% 4142
2026
Q1 		$276K Buy
30,651
+18,984
+163% +$300K ﹤0.01% 3878
2025
Q4 		$213K Sell
11,667
-42,561
-78% -$717K ﹤0.01% 4110
2025
Q3 		$918K Sell
54,228
-11,944
-18% -$205K ﹤0.01% 2881
2025
Q2 		$1.2M Sell
66,172
-1,575
-2% -$32.1K ﹤0.01% 2356
2025
Q1 		$1.34M Buy
67,747
+56,910
+525% +$984K ﹤0.01% 1981
2024
Q4 		$186K Sell
10,837
-2,861
-21% -$53.8K ﹤0.01% 3665
2024
Q3 		$274K Sell
13,698
-62,364
-82% -$970K ﹤0.01% 3392
2024
Q2 		$850K Buy
76,062
+33,978
+81% +$285K ﹤0.01% 2325
2024
Q1 		$278K Buy
42,084
+520
+1% +$2.84K ﹤0.01% 3398
2023
Q4 		$188K Buy
41,564
+1,117
+3% +$4.13K ﹤0.01% 3973
2023
Q3 		$145K Buy
40,447
+5,634
+16% +$21.7K ﹤0.01% 4223
2023
Q2 		$128K Sell
34,813
-1,854
-5% -$6.87K ﹤0.01% 4247
2023
Q1 		$121K Buy
36,667
+741
+2% +$2.56K ﹤0.01% 4285
2022
Q4 		$139K Hold
35,926
– – ﹤0.01% 4157
2022
Q3 		$87K Buy
35,926
+2,000
+6% +$4.8K ﹤0.01% 4483
2022
Q2 		$67K Buy
33,926
+28,650
+543% +$56.4K ﹤0.01% 4723
2022
Q1 		$9K Buy
5,276
+1,000
+23% +$1.56K ﹤0.01% 6187
2021
Q4 		$6K Sell
4,276
-8,098
-65% -$10.6K ﹤0.01% 6517
2021
Q3 		$14K Sell
12,374
-1,500
-11% -$2.1K ﹤0.01% 6000
2021
Q2 		$23K Sell
13,874
-10,366
-43% -$18.2K ﹤0.01% 5560
2021
Q1 		$42K Sell
24,240
-19,954
-45% -$45.7K ﹤0.01% 4990
2020
Q4 		$86K Buy
44,194
+9,759
+28% +$20.5K ﹤0.01% 4158
2020
Q3 		$82K Buy
34,435
+29,435
+589% +$80.7K ﹤0.01% 3965
2020
Q2 		$15K Buy
+5,000
New +$14.4K ﹤0.01% 4948

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Osaic Holdings's ADMA Position: Q2 2026 in Review

Osaic Holdings increased its ADMA Biologics (ADMA) stake by 10% in Q2 2026, buying an estimated $28.7K and bringing the position to 33,798 shares worth $283K. The position accounts for ﹤0.01% of the portfolio, ranked #4142.

Osaic Holdings first reported a position in ADMA in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.34M in Q1 2025. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Osaic Holdings held 33,798 shares of ADMA Biologics worth $283K as of Q2 2026.
  • Osaic Holdings bought 3,147 ADMA Biologics shares in Q2 2026, an estimated $28.7K.
  • ADMA Biologics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4142 holding.
  • Osaic Holdings first reported a position in ADMA Biologics in Q2 2020 and has held it in 25 quarters since.
  • Osaic Holdings's ADMA Biologics position peaked at $1.34M in Q1 2025.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.